BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 20182429)

  • 1. Delayed onset of severe neonatal toxoplasmosis.
    Al-Hamod D; Vauloup C; Goulet M; Zupan-Simunek V; Castel C; Boileau P
    J Perinatol; 2010 Mar; 30(3):231-2. PubMed ID: 20182429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Congenital toxoplasmosis following infection occurring late in pregnancy].
    Ben Abdallah R; Siala E; Maatoug R; Souissi O; Aoun K; Bouratbine A
    Arch Pediatr; 2011 Jul; 18(7):758-60. PubMed ID: 21632221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of post-partum diagnosis of congenital toxoplasmosis primary maternal infection at the end of the pregnancy].
    Wirden M; Botterel F; Romand S; Ithier G; Bourée P
    J Gynecol Obstet Biol Reprod (Paris); 1999 Oct; 28(6):566-7. PubMed ID: 10598352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiology casebook. Congenital toxoplasmosis: a case report.
    Pan J; Carey BE
    J Perinatol; 1998; 18(6 Pt 1):489-91. PubMed ID: 9848769
    [No Abstract]   [Full Text] [Related]  

  • 5. Congenital toxoplasmosis in a neonate with significant neurologic manifestations.
    Chuang YC; Chen JY; Ji DD; Su PH
    J Formos Med Assoc; 2012 Apr; 111(4):232-3. PubMed ID: 22526213
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic problems and postnatal follow-up in congenital toxoplasmosis.
    Mazzola A; Casuccio A; Romano A; Schimmenti MG; Titone L; Di Carlo P
    Minerva Pediatr; 2007 Jun; 59(3):207-13. PubMed ID: 17519865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The child with congenital toxoplasmosis.
    McLeod R; Boyer K; Roizen N; Stein L; Swisher C; Holfels E; Hopkins J; Mack D; Karrison T; Patel D; Pfiffner L; Remington J; Withers S; Meyers S; Aitchison V; Mets M; Rabiah P; Meier P
    Curr Clin Top Infect Dis; 2000; 20():189-208. PubMed ID: 10943525
    [No Abstract]   [Full Text] [Related]  

  • 8. Neurologic and developmental outcome in treated congenital toxoplasmosis.
    Roizen N; Swisher CN; Stein MA; Hopkins J; Boyer KM; Holfels E; Mets MB; Stein L; Patel D; Meier P
    Pediatrics; 1995 Jan; 95(1):11-20. PubMed ID: 7770286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.
    McLeod R; Boyer K; Karrison T; Kasza K; Swisher C; Roizen N; Jalbrzikowski J; Remington J; Heydemann P; Noble AG; Mets M; Holfels E; Withers S; Latkany P; Meier P;
    Clin Infect Dis; 2006 May; 42(10):1383-94. PubMed ID: 16619149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Letter: Significance of Toxoplasma infections for public health].
    Koppe JG
    Ned Tijdschr Geneeskd; 1975 Sep; 119(38):1477. PubMed ID: 1165816
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital toxoplasmosis: therapeutic strategies.
    Foulon W
    Arch Pediatr; 2003 Feb; 10 Suppl 1():10-1. PubMed ID: 12802954
    [No Abstract]   [Full Text] [Related]  

  • 12. [Analysis of a case of severe congenital toxoplasmosis].
    Pujol-Riqué M; Gómez-López L; Tudó G; Falgueras T; Costa J; Rodríguez-Miguélez JM; Coll O; Valls ME
    Med Clin (Barc); 1999 Nov; 113(18):701-3. PubMed ID: 10650573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of congenital toxoplasmosis.
    Foulon W; Naessens A; Ho-Yen D
    J Perinat Med; 2000; 28(5):337-45. PubMed ID: 11125923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine.
    Schmidt DR; Hogh B; Andersen O; Hansen SH; Dalhoff K; Petersen E
    Eur J Pediatr; 2006 Jan; 165(1):19-25. PubMed ID: 16133245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Septic shock due to congenital disseminated toxoplasmosis?].
    Cneude F; Deliège R; Barbier C; Durand-Joly I; Bourlet A; Sonna M; El Kohen R; Locquet A; Vittu G; Decoster A
    Arch Pediatr; 2003 Apr; 10(4):326-8. PubMed ID: 12818753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination.
    Villena I; Quereux C; Pinon JM
    Prenat Diagn; 1998 Jul; 18(7):754-6. PubMed ID: 9706662
    [No Abstract]   [Full Text] [Related]  

  • 17. Longitudinal study of new eye lesions in treated congenital toxoplasmosis.
    Phan L; Kasza K; Jalbrzikowski J; Noble AG; Latkany P; Kuo A; Mieler W; Meyers S; Rabiah P; Boyer K; Swisher C; Mets M; Roizen N; Cezar S; Remington J; Meier P; McLeod R;
    Ophthalmology; 2008 Mar; 115(3):553-559.e8. PubMed ID: 17825418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on the development of fetus and infant congenitally infected by Toxoplasma gondii and intervention].
    Yuan WY; Wu YP; Geng X; Geng DH; Zhao S; Xue J
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb; 25(1):79-80, I. PubMed ID: 17639710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital toxoplasmosis from an HIV-infected woman as a result of reactivation.
    Bachmeyer C; Mouchnino G; Thulliez P; Blum L
    J Infect; 2006 Feb; 52(2):e55-7. PubMed ID: 16043225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital toxoplasmosis].
    Padelt H
    Z Arztl Fortbild (Jena); 1982 Sep; 76(18):828-31. PubMed ID: 6758380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.